Dr. Christopher Stephen Lange, SB, DPhil., KCOM, is recognized by Continental Who's Who

Saturday, February 11, 2017 General News
Email Print This Page Comment
Font : A-A+

NEW YORK, Feb. 10, 2017 /PRNewswire/ -- Dr. Christopher Stephen Lange, SB, DPhil., KCOM, is

recognized by Continental Who's Who as a Pinnacle Professional in the field of Medicine. Dr. Lange is a Professor and Associate Chair of Radiation Oncology at SUNY Downstate Medical Center.

As one of the largest colleges

of medicine in New York, the SUNY Downstate Medical Center is the only academic medical center combining health education, research, and patient care services to the residents of Brooklyn.

An esteemed physician, instructor and researcher, Dr. Lange began his healthcare career in 1962 and has been working for SUNY Downstate for over thirty years. He is currently the Director of Radiation Research, Associate Director of Residency Program and Associate Chair of Radiation Oncology Department.

Presently, his main area of focus lies in patented hybrid spheroid assay measuring sensitivity of cancer treatments with further expertise in assay development, cell biology, cancer research, radiation therapy, molecular biology, stem cells and much more.

A testament to his success and determination, Dr. Lange holds a US Patent (Methods of Assaying Sensitivity of Cancer Stem Cells to Therapeutic Modalities) which ultimately allows the individualization of cancer treatment selection for unparalleled results for each patient.

Dr. Lange graduated from the University of Oxford with his D.Phil., Fac. Med. (Radiation Biophysics) following receipt of his S.B. degree in Physics from the Massachusetts Institute of Technology.

For more information, please visit www.downstate.edu.

Contact: Katherine Green, 516-825-5634, pr@continentalwhoswho.com  

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/dr-christopher-stephen-lange-sb-dphil-kcom-is-recognized-by-continental-whos-who-300405744.html

SOURCE Continental Who's Who



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook